Periodic Reporting for period 2 - RegSign (A multi-parametric Regulatory T cell Atlas in cancer to predict immunotherapy response, adverse autoimmune events and to identify novel therapeutic targets)

Cancer remains the second leading cause of death globally with a rising burden of 18.1 million new cases and 9.6 million deaths in 2020. Recent breakthroughs in the field of immunology have revolutionised anti-cancer therapy, giving rise to the era of immunotherapy...